2024 Q1 Form 10-Q Financial Statement

#000121390024043619 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q1
Revenue $124.8K $80.86K $61.14K
YoY Change 104.21% 28.41% -51.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.512M $1.429M $1.132M
YoY Change 33.5% 384.11%
% of Gross Profit
Research & Development $119.0K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $1.068K $510.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.512M $1.429M $1.132M
YoY Change 33.5% 384.11% 438.57%
Operating Profit -$1.387M -$1.071M
YoY Change 29.47% 1172.27%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.387M -$1.348M -$1.071M
YoY Change 29.47% 480.56%
Income Tax
% Of Pretax Income
Net Earnings -$1.387M -$1.348M -$1.071M
YoY Change 29.47% 480.56% 1172.27%
Net Earnings / Revenue -1110.94% -1667.57% -1752.27%
Basic Earnings Per Share -$0.10 -$0.09
Diluted Earnings Per Share -$0.36 -$0.09 -$0.09
COMMON SHARES
Basic Shares Outstanding 14.17M shares 12.46M shares
Diluted Shares Outstanding 13.58M shares 12.46M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.870M $2.924M $5.922M
YoY Change -68.43% 2031.74%
Cash & Equivalents $1.870M $2.924M $5.922M
Short-Term Investments
Other Short-Term Assets $151.3K $38.68K $86.43K
YoY Change 75.02% -83.6%
Inventory
Prepaid Expenses $151.3K $38.68K $86.43K
Receivables $2.995K
Other Receivables $0.00
Total Short-Term Assets $2.021M $2.963M $6.012M
YoY Change -66.38% 694.33%
LONG-TERM ASSETS
Property, Plant & Equipment $23.66K $12.83K
YoY Change
Goodwill
YoY Change
Intangibles $100.0K $100.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $123.7K $112.8K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.021M $2.963M $6.012M
Total Long-Term Assets $123.7K $112.8K $0.00
Total Assets $2.145M $3.076M $6.012M
YoY Change -64.32% 724.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $2.031K $3.445K $4.045K
YoY Change -49.79% -25.88%
Short-Term Debt $280.4K $150.1K $184.5K
YoY Change 51.99% -30.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $282.5K $153.5K $188.5K
YoY Change 49.81% -29.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $282.5K $153.5K $188.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $282.5K $153.5K $188.5K
YoY Change 49.81% -29.97%
SHAREHOLDERS EQUITY
Retained Earnings -$6.945M -$5.558M -$1.698M
YoY Change 308.93% 786.33%
Common Stock $8.983M $0.00 $7.520M
YoY Change 19.45% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $176.9K
YoY Change
Treasury Stock Shares
Shareholders Equity $1.862M $2.922M $5.823M
YoY Change
Total Liabilities & Shareholders Equity $2.145M $3.076M $6.012M
YoY Change -64.32% 724.57%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.387M -$1.348M -$1.071M
YoY Change 29.47% 480.56% 1172.27%
Depreciation, Depletion And Amortization $1.068K $510.00 $0.00
YoY Change
Cash From Operating Activities -$1.043M -$854.1K -$829.9K
YoY Change 25.63% 307.43% 1005.46%
INVESTING ACTIVITIES
Capital Expenditures $11.90K $106.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$11.90K -$106.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -136.7K $6.615M
YoY Change -141.44% 8720.16%
NET CHANGE
Cash From Operating Activities -$1.043M -854.1K -$829.9K
Cash From Investing Activities -$11.90K -106.0K
Cash From Financing Activities -136.7K $6.615M
Net Change In Cash -$1.055M -1.097M $5.785M
YoY Change -118.23% -1011.91% -7513312.99%
FREE CASH FLOW
Cash From Operating Activities -$1.043M -$854.1K -$829.9K
Capital Expenditures $11.90K $106.0K
Free Cash Flow -$1.055M -$960.1K -$829.9K
YoY Change 27.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13577993 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41612
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
ASSET ENTITIES INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1293236
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Crescent Ct
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2024Q1 dei City Area Code
CityAreaCode
(214)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
459-3117
CY2024Q1 dei Security12b Title
Security12bTitle
Class B Common Stock, $0.0001 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
ASST
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1869786 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2924323 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
151274 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
38681 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2021060 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2963004 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23659 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12825 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100000 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
123659 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
112825 usd
CY2024Q1 us-gaap Assets
Assets
2144719 usd
CY2023Q4 us-gaap Assets
Assets
3075829 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
280433 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
150096 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2031 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3445 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
282464 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
153541 usd
CY2024Q1 us-gaap Liabilities
Liabilities
282464 usd
CY2023Q4 us-gaap Liabilities
Liabilities
153541 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
176876 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
176876 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8982907 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8656036 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6945219 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5558315 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1862255 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2922288 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2144719 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3075829 usd
CY2024Q1 us-gaap Revenues
Revenues
124841 usd
CY2023Q1 us-gaap Revenues
Revenues
61135 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
127139 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
36581 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
522039 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
345941 usd
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
862567 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
749864 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1511745 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1132386 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1386904 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071251 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1386904 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14174410 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12464256 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2922288 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
326871 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1386904 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1862255 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
153783 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6540493 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
200210 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5823235 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1386904 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
326871 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
200210 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1068 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2995 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
112593 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
86432 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
130337 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
131125 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1414 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-603 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1042635 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-829946 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11902 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11902 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6615120 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6615120 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1054537 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5785174 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2924323 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137177 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1869786 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5922351 usd
CY2024Q1 asst Conversion From Class A To Class B Common Stock
ConversionFromClassAToClassBCommonStock
85 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6945219 usd
CY2024Q1 us-gaap Cash
Cash
1869786 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1386904 usd
CY2023 asst Purchase Of Second Triton Shares
PurchaseOfSecondTritonShares
621590 shares
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p>
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250000 usd
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1380000 usd
CY2024Q1 us-gaap Management Fee Payable
ManagementFeePayable
143915 usd
CY2023Q1 us-gaap Management Fee Payable
ManagementFeePayable
19697 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
119009 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2031 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3445 usd
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
862567 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
749864 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25461 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13559 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1802 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
734 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23659 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12825 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1068 usd
CY2023Q1 us-gaap Depreciation
Depreciation
0 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
100000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
100000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
250000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
250000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.0999 pure
CY2023Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1000000 usd
CY2023Q3 us-gaap Percentage Of Weighted Average Cost Inventory
PercentageOfWeightedAverageCostInventory
0.85 pure
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
326871 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200210 usd
CY2024Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
211341 usd
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
16907 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.34
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10249315 shares
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 asst Conversion From Class A To Class B Common Stock
ConversionFromClassAToClassBCommonStock
usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2023 asst Recognized Over Weightedaverage Period
RecognizedOverWeightedaveragePeriod
P1Y317D
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001920406

Files In Submission

Name View Source Status
asst-20240331_cal.xml Edgar Link unprocessable
0001213900-24-043619-index-headers.html Edgar Link pending
0001213900-24-043619-index.html Edgar Link pending
0001213900-24-043619.txt Edgar Link pending
0001213900-24-043619-xbrl.zip Edgar Link pending
asst-20240331.xsd Edgar Link pending
ea0205923-10q_asset.htm Edgar Link pending
ea020592301ex10-2_asset.htm Edgar Link pending
ea020592301ex10-3_asset.htm Edgar Link pending
ea020592301ex10-4_asset.htm Edgar Link pending
ea020592301ex10-5_asset.htm Edgar Link pending
ea020592301ex10-6_asset.htm Edgar Link pending
ea020592301ex10-7_asset.htm Edgar Link pending
ea020592301ex31-1_asset.htm Edgar Link pending
ea020592301ex31-2_asset.htm Edgar Link pending
ea020592301ex32-1_asset.htm Edgar Link pending
ea020592301ex32-2_asset.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
asst-20240331_def.xml Edgar Link unprocessable
asst-20240331_lab.xml Edgar Link unprocessable
asst-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0205923-10q_asset_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending